Search - tctmd.com

Displaying 321 - 340 of 634

Sort: Relevancy | Date

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

News Conference News ISC 2019

MISTIE III Misses Primary Endpoint, but Stroke Experts See Encouraging Results

February 08, 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

News Conference News ISC 2019

Off-Label Underdosing of DOACs Tied to Worse Outcomes in A-fib Patients

February 07, 2019

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

News Features

Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis?

Michael O'Riordan

February 01, 2019

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

January 23, 2019

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

News Daily News

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

January 14, 2019

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

News Daily News

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Yael L. Maxwell

January 09, 2019

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

January 04, 2019

Top News in Structural Heart Disease: 2018

News Features

Top News in Structural Heart Disease: 2018

December 28, 2018

Man’s Best Friend, Especially After an MI or Stroke

News Conference News WCC 2018

Man’s Best Friend, Especially After an MI or Stroke

December 11, 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

News Conference News AHA 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

November 11, 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

News Conference News AHA 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

November 10, 2018

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

October 31, 2018

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

News Daily News

Long-term Risk Factor Control Linked to Survival in COURAGE Substudy

Yael L. Maxwell

October 30, 2018

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

News Daily News

Elevated Lp(a), Even in Statin-Treated Patients, Linked With Higher CVD Risks

Michael O'Riordan

October 15, 2018

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

October 04, 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

August 27, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.